1. Home
  2. ADAP vs GFAI Comparison

ADAP vs GFAI Comparison

Compare ADAP & GFAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADAP
  • GFAI
  • Stock Information
  • Founded
  • ADAP 2008
  • GFAI 2018
  • Country
  • ADAP United Kingdom
  • GFAI Singapore
  • Employees
  • ADAP N/A
  • GFAI N/A
  • Industry
  • ADAP Biotechnology: Pharmaceutical Preparations
  • GFAI Diversified Commercial Services
  • Sector
  • ADAP Health Care
  • GFAI Consumer Discretionary
  • Exchange
  • ADAP Nasdaq
  • GFAI Nasdaq
  • Market Cap
  • ADAP 21.3M
  • GFAI 24.6M
  • IPO Year
  • ADAP 2015
  • GFAI N/A
  • Fundamental
  • Price
  • ADAP $0.08
  • GFAI $1.01
  • Analyst Decision
  • ADAP Hold
  • GFAI Strong Buy
  • Analyst Count
  • ADAP 6
  • GFAI 1
  • Target Price
  • ADAP $1.02
  • GFAI $4.50
  • AVG Volume (30 Days)
  • ADAP 106.3M
  • GFAI 534.6K
  • Earning Date
  • ADAP 11-12-2025
  • GFAI 09-23-2025
  • Dividend Yield
  • ADAP N/A
  • GFAI N/A
  • EPS Growth
  • ADAP N/A
  • GFAI N/A
  • EPS
  • ADAP N/A
  • GFAI N/A
  • Revenue
  • ADAP $65,084,999.00
  • GFAI $36,987,715.00
  • Revenue This Year
  • ADAP N/A
  • GFAI $5.66
  • Revenue Next Year
  • ADAP $24.70
  • GFAI $4.69
  • P/E Ratio
  • ADAP N/A
  • GFAI N/A
  • Revenue Growth
  • ADAP N/A
  • GFAI 4.38
  • 52 Week Low
  • ADAP $0.04
  • GFAI $0.76
  • 52 Week High
  • ADAP $0.86
  • GFAI $3.88
  • Technical
  • Relative Strength Index (RSI)
  • ADAP 41.40
  • GFAI 35.81
  • Support Level
  • ADAP $0.04
  • GFAI $1.02
  • Resistance Level
  • ADAP $0.24
  • GFAI $1.08
  • Average True Range (ATR)
  • ADAP 0.04
  • GFAI 0.06
  • MACD
  • ADAP -0.01
  • GFAI -0.01
  • Stochastic Oscillator
  • ADAP 15.65
  • GFAI 0.00

About ADAP Adaptimmune Therapeutics plc

Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.

About GFAI Guardforce AI Co. Limited

Guardforce AI Co Ltd is an integrated solution provider, specializing in security solutions, and also focuses on implementing AI and robotics solutions to improve business operational efficiency and sales and marketing processes, especially for the retail and travel industry in the Asia Pacific. The company's operating business segments include Secured Logistics, AI & Robotics Solution Business, General Security Solutions, and Corporate and others. A majority of its revenue is generated from the Secured Logistics segment, which includes services like cash-in-transit, dedicated vehicles to banks, ATM management, cash center operations, cash processing, coin processing, cheque center, and cash deposit machine solutions.

Share on Social Networks: